Journey Medical (DERM) Amortization of Deferred Charges (2020 - 2023)

Journey Medical has reported Amortization of Deferred Charges for 4 years, with the latest figure at $177000.0 in Q3 2023.

• For the quarter ending Q3 2023, Amortization of Deferred Charges fell 11.94% year-over-year to $177000.0; the trailing twelve-month figure through Dec 2023 stood at $353000.0 (down 54.16% YoY), and the FY2023 full-year result was $353000.0, down 54.16% from the prior year.
• Amortization of Deferred Charges for Q3 2023 stood at $177000.0, up from $78000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $804000.0 in Q2 2021, with the low at -$409000.0 in Q3 2021.
• Historically, Amortization of Deferred Charges has averaged $175833.3 across 4 years, with a median of $189000.0 in 2022.
• The largest YoY upside for Amortization of Deferred Charges was 149.14% in 2022 against a maximum downside of 73.26% in 2022.
• Journey Medical's Amortization of Deferred Charges stood at $206000.0 in 2020, then retreated by 19.9% to $165000.0 in 2021, then decreased by 8.48% to $151000.0 in 2022, then advanced by 17.22% to $177000.0 in 2023.
• The last three Amortization of Deferred Charges figures came in at $177000.0 (Q3 2023), $78000.0 (Q2 2023), and $98000.0 (Q1 2023), per Business Quant data.